{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:05:08Z","timestamp":1759939508562,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"This work was supported by the grants from the National Natural Science Foundation of China","award":["81300962"],"award-info":[{"award-number":["81300962"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12871-017-0353-z","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T09:50:30Z","timestamp":1493286630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of colloid pre-loading on thromboelastography during elective intracranial tumor surgery in pediatric patients: hydroxyethyl starch 130\/0.4 versus 5% human albumin"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-9366","authenticated-orcid":false,"given":"Yuanzhi","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianer","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s001010050667","volume":"48","author":"U Schwarz","year":"1999","unstructured":"Schwarz U. Intraoperative fluid therapy in infants and young children. Anaesthesist. 1999;48:41\u201350.","journal-title":"Anaesthesist"},{"key":"353_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1213\/ANE.0b013e3181b6b3b5","volume":"110","author":"AG Bailey","year":"2010","unstructured":"Bailey AG, McNaull PP, Jooste E, Tuchman JB. Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here? Anesth Analg. 2010;110:375\u201390.","journal-title":"Anesth Analg"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1365-2044.2007.05186.x","volume":"62","author":"T Haas","year":"2007","unstructured":"Haas T, Preinreich A, Oswald E, Pajk W, Berger J, Kuehbacher G, Innerhofer P. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia. 2007;62:1000\u20137.","journal-title":"Anaesthesia"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1046\/j.1460-9592.2001.00736.x","volume":"11","author":"M Soderlind","year":"2001","unstructured":"Soderlind M, Salvignol G, Izard P, Lonnqvist PA. Use of albumin, blood transfusion and intraoperative glucose by APA and ADARPEF members: a postal survey. Paediatr Anaesth. 2001;11:685\u20139.","journal-title":"Paediatr Anaesth"},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/01.anes.0000265422.07864.37","volume":"106","author":"SD Gandhi","year":"2007","unstructured":"Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130\/0.4) or hetastarch. Anesthesiology. 2007;106:1120\u20137.","journal-title":"Anesthesiology"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00126839-200405010-00001","volume":"5","author":"C Jungheinrich","year":"2004","unstructured":"Jungheinrich C, Sauermann W, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130\/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study. Drugs R D. 2004;5:1\u20139.","journal-title":"Drugs R D"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/bja\/aeq084","volume":"104","author":"A Schramko","year":"2010","unstructured":"Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth. 2010;104:691\u20137.","journal-title":"Br J Anaesth"},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1213\/ANE.0b013e31827175da","volume":"116","author":"P Linden Van Der","year":"2013","unstructured":"Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013;116:35\u201348.","journal-title":"Anesth Analg"},{"key":"353_CR9","doi-asserted-by":"publisher","unstructured":"McAlister V, Burns KE, Znajda T, Church B. Hypertonic saline for perioperative fluid management. Cochrane Database Syst Rev. 2010:D5576","DOI":"10.1213\/ANE.0b013e3181d5daf8"},{"key":"353_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.6061\/clinics\/2013(03)OA07","volume":"68","author":"L Shao","year":"2013","unstructured":"Shao L, Wang B, Wang S, Mu F, Gu K. Comparison of 7.2% hypertonic saline - 6% hydroxyethyl starch solution and 6% hydroxyethyl starch solution after the induction of anesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo). 2013;68:323\u20138.","journal-title":"Clinics (Sao Paulo)"},{"key":"353_CR11","first-page":"584","volume":"76","author":"YS Choi","year":"2010","unstructured":"Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130\/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010;76:584\u201391.","journal-title":"Minerva Anestesiol"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1213\/00000539-199701000-00037","volume":"84","author":"BB Warren","year":"1997","unstructured":"Warren BB, Durieux ME. Hydroxyethyl starch: safe or not? Anesth Analg. 1997;84:206\u201312.","journal-title":"Anesth Analg"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1213\/01.ANE.0000061582.09963.FD","volume":"96","author":"TA Neff","year":"2003","unstructured":"Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130\/0.4 in patients with severe head injury. Anesth Analg. 2003;96:1453\u20139.","journal-title":"Anesth Analg"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00000542-200307000-00010","volume":"99","author":"SM Kasper","year":"2003","unstructured":"Kasper SM, Meinert P, Kampe S, Gorg C, Geisen C, Mehlhorn U, Diefenbach C. Large-dose hydroxyethyl starch 130\/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200\/0.5 at recommended doses. Anesthesiology. 2003;99:42\u20137.","journal-title":"Anesthesiology"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/00000539-200002000-00007","volume":"90","author":"CJ Konrad","year":"2000","unstructured":"Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer\u2019s solution on coagulation using SONOCLOT. Anesth Analg. 2000;90:274\u20139.","journal-title":"Anesth Analg"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12871-016-0236-8","volume":"16","author":"S Sudfeld","year":"2016","unstructured":"Sudfeld S, Leyh-Bannurah SR, Budaus L, Graefen M, Reese PC, von Breunig F, Reuter DA, Saugel B. Impact of perioperative administration of 6% hydroxyethyl starch 130\/0.4 on serum cystatin C-derived renal function after radical prostatectomy: a single-centre retrospective study. BMC Anesthesiol. 2016;16:69.","journal-title":"BMC Anesthesiol"},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s001340101107","volume":"27","author":"E Jonge de","year":"2001","unstructured":"de Jonge E, Levi M, Buller HR, Berends F, Kesecioglu J. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200\/0.5\/6) in healthy human subjects. Intensive Care Med. 2001;27:1825\u20139.","journal-title":"Intensive Care Med"},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/bja\/82.2.175","volume":"82","author":"S Karoutsos","year":"1999","unstructured":"Karoutsos S, Nathan N, Lahrimi A, Grouille D, Feiss P, Cox DJ. Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth. 1999;82:175\u20137.","journal-title":"Br J Anaesth"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/CCM.0b013e3181958c81","volume":"37","author":"C Hanart","year":"2009","unstructured":"Hanart C, Khalife M, De Ville A, Otte F, De Hert S, Van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130\/0.4. Crit Care Med. 2009;37:696\u2013701.","journal-title":"Crit Care Med"},{"key":"353_CR20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/00000542-200509000-00031","volume":"103","author":"SA Kozek-Langenecker","year":"2005","unstructured":"Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology. 2005;103:654\u201360.","journal-title":"Anesthesiology"},{"key":"353_CR21","doi-asserted-by":"publisher","first-page":"R208","DOI":"10.1186\/cc8223","volume":"13","author":"M Sossdorf","year":"2009","unstructured":"Sossdorf M, Marx S, Schaarschmidt B, Otto GP, Claus RA, Reinhart K, Hartog CS, Losche W. HES 130\/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care. 2009;13:R208.","journal-title":"Crit Care"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/00000539-200106000-00008","volume":"92","author":"A Franz","year":"2001","unstructured":"Franz A, Braunlich P, Gamsjager T, Felfern M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg. 2001;92:1402\u20137.","journal-title":"Anesth Analg"},{"key":"353_CR23","first-page":"989","volume":"87","author":"M Jamnicki","year":"1998","unstructured":"Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130\/0.4 and hydroxyethyl starch 200\/0.5 using thrombelastography. Anesth Analg. 1998;87:989\u201393.","journal-title":"Anesth Analg"},{"issue":"Suppl. 2","key":"353_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/cc1996","volume":"7","author":"HGC Lochb\u00fchler","year":"2003","unstructured":"Lochb\u00fchler HGC, Hagemann H. Hydroxyethyl starch HES 130 \u2044 0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study. Crit Care. 2003;7 Suppl 2:107.","journal-title":"Crit Care"},{"key":"353_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1399-6576.2005.00881.x","volume":"50","author":"K Chong Sung","year":"2006","unstructured":"Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung Ok K. Effects of intravascular volume therapy using hydroxyethyl starch (130\/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand. 2006;50:108\u201311.","journal-title":"Acta Anaesthesiol Scand"},{"key":"353_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1460-9592.2011.03776.x","volume":"22","author":"R Sumpelmann","year":"2012","unstructured":"Sumpelmann R, Kretz FJ, Luntzer R, de Leeuw TG, Mixa V, Gabler R, Eich C, Hollmann MW, Osthaus WA. Hydroxyethyl starch 130\/0.42\/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS). Paediatr Anaesth. 2012;22:371\u20138.","journal-title":"Paediatr Anaesth"},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/bja\/aet229","volume":"111","author":"S Ogawa","year":"2013","unstructured":"Ogawa S, Ohnishi T, Hosokawa K, Szlam F, Chen EP, Tanaka KA. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. Br J Anaesth. 2013;111:1013\u201323.","journal-title":"Br J Anaesth"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-017-0353-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T09:50:54Z","timestamp":1493286654000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-017-0353-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1186\/s12871-017-0353-z","relation":{},"ISSN":["1471-2253"],"issn-type":[{"type":"electronic","value":"1471-2253"}],"subject":[],"published":{"date-parts":[[2017,4,27]]},"article-number":"62"}}